These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 13679459)

  • 1. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
    Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
    Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
    Reed AL; Califano J; Cairns P; Westra WH; Jones RM; Koch W; Ahrendt S; Eby Y; Sewell D; Nawroz H; Bartek J; Sidransky D
    Cancer Res; 1996 Aug; 56(16):3630-3. PubMed ID: 8705996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
    J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Shete S; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):640-5. PubMed ID: 12101111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.
    O'Regan EM; Toner ME; Finn SP; Fan CY; Ring M; Hagmar B; Timon C; Smyth P; Cahill S; Flavin R; Sheils OM; O'Leary JJ
    Hum Pathol; 2008 Mar; 39(3):452-8. PubMed ID: 18261630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.